121 related articles for article (PubMed ID: 24200706)
1. Reply to 'Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.'.
Raju A; Khundkar R
J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):412-3. PubMed ID: 24200706
[No Abstract] [Full Text] [Related]
2. Response from the authors of 'Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group'.
de Graaf M; Raphael MF; Breugem CC; Knol MJ; Bruijnzeel-Koomen CA; Kon M; Breur JM; Pasmans SG
J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):411-2. PubMed ID: 24238766
[No Abstract] [Full Text] [Related]
3. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.
de Graaf M; Raphael MF; Breugem CC; Knol MJ; Bruijnzeel-Koomen CA; Kon M; Breur JM; Pasmans SG
J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1732-40. PubMed ID: 24011909
[TBL] [Abstract][Full Text] [Related]
4. Ulcerated infantile haemangiomas: the effect of the selective beta-blocker atenolol on wound healing.
Ruitenberg G; Young-Afat DA; de Graaf M; Pasmans SG; Breugem CC
Br J Dermatol; 2016 Dec; 175(6):1357-1360. PubMed ID: 27105937
[No Abstract] [Full Text] [Related]
5. Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase: A Retrospective Noninferiority Study.
Bayart CB; Tamburro JE; Vidimos AT; Wang L; Golden AB
Pediatr Dermatol; 2017 Jul; 34(4):413-421. PubMed ID: 28556385
[TBL] [Abstract][Full Text] [Related]
6. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
Phillips RJ; Penington AJ; Bekhor PS; Crock CM
J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
[TBL] [Abstract][Full Text] [Related]
7. Atenolol: a promising alternative to propranolol for the treatment of hemangiomas.
Raphaël MF; de Graaf M; Breugem CC; Pasmans SGMA; Breur JMPJ
J Am Acad Dermatol; 2011 Aug; 65(2):420-421. PubMed ID: 21763565
[No Abstract] [Full Text] [Related]
8. Propranolol-resistant infantile haemangiomas.
Caussé S; Aubert H; Saint-Jean M; Puzenat E; Bursztejn AC; Eschard C; Mahé E; Maruani A; Mazereeuw-Hautier J; Dreyfus I; Miquel J; Chiaverini C; Boccara O; Hadj-Rabia S; Stalder JF; Barbarot S;
Br J Dermatol; 2013 Jul; 169(1):125-9. PubMed ID: 23659587
[TBL] [Abstract][Full Text] [Related]
9. Haemangioma and propranolol.
Engberg Damsgaard T; Vandborg Bjerre J
J Plast Surg Hand Surg; 2014 Feb; 48(1):86-8. PubMed ID: 23837510
[TBL] [Abstract][Full Text] [Related]
10. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
Holmes WJ; Mishra A; Gorst C; Liew SH
J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
[TBL] [Abstract][Full Text] [Related]
11. Atenolol treatment for severe Infantile Hemangiomas: a single-centre prospective study.
Alexopoulos A; Thanopoulou I; Dakoutrou M; Georgiadou E; Chrousos GP; Kakourou T
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):e117-e119. PubMed ID: 28921662
[No Abstract] [Full Text] [Related]
12. [Propranolol therapy for periocular and orbital infantile haemangiomas].
Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
[TBL] [Abstract][Full Text] [Related]
13. Atenolol use for infantile hemangiomas.
Ballona R; Velásquez' F; Kikushima I; Zevallos JP; Nuñez J; Apagüeño C
Indian J Dermatol Venereol Leprol; 2021; 87(2):321. PubMed ID: 33769740
[No Abstract] [Full Text] [Related]
14. Successful treatment of infantile haemangiomas of the orbit with propranolol.
Li YC; McCahon E; Rowe NA; Martin PA; Wilcsek GA; Martin FJ
Clin Exp Ophthalmol; 2010 Aug; 38(6):554-9. PubMed ID: 20491798
[TBL] [Abstract][Full Text] [Related]
15. [Propranolol in infantile hemangiomas].
Léauté-Labrèze C
Arch Pediatr; 2015 Apr; 22(4):452-5. PubMed ID: 25753275
[TBL] [Abstract][Full Text] [Related]
16. Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature.
Oksiuta M; Matuszczak E; Debek W; Dzienis-Koronkiewicz E; Hermanowicz A
J Matern Fetal Neonatal Med; 2016; 29(1):64-8. PubMed ID: 25385271
[TBL] [Abstract][Full Text] [Related]
17. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.
Ábarzúa-Araya A; Navarrete-Dechent CP; Heusser F; Retamal J; Zegpi-Trueba MS
J Am Acad Dermatol; 2014 Jun; 70(6):1045-9. PubMed ID: 24656727
[TBL] [Abstract][Full Text] [Related]
18. Propranolol was effective in treating cutaneous infantile haemangiomas in Thai children.
Techasatian L; Komwilaisak P; Panombualert S; Uppala R; Jetsrisuparb C
Acta Paediatr; 2016 Jun; 105(6):e257-62. PubMed ID: 26919396
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of systemic propranolol for the treatment of complicated infantile haemangiomas.
Schneider M; Cremer HJ; Ruef P
Acta Paediatr; 2014 Sep; 103(9):977-83. PubMed ID: 24837972
[TBL] [Abstract][Full Text] [Related]
20. Infantile hemangioma associated with PHACES syndrome showing a dramatic response to oral propranolol.
Singh BA; Harsha YS; Reddy BS
Indian J Dermatol Venereol Leprol; 2015; 81(5):549. PubMed ID: 26087086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
